BOUCENNA, A.; HIRECH, A.; LARBI, R. M.; SATTA, D. Impact of CYP2D6 Polymorphisms in Predicting Occurrence of Adverse Effect to Tamoxifen and Developing Recurrence in ER+ Breast Cancer Patients. Archives of Breast Cancer, [S. l.], v. 11, n. 4, 2024. DOI: 10.32768/abc.2024114392-399. Disponível em: https://archbreastcancer.com/index.php/abc/article/view/988. Acesso em: 23 jan. 2025.